Viewing Study NCT03571360


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-25 @ 3:53 AM
Study NCT ID: NCT03571360
Status: UNKNOWN
Last Update Posted: 2020-06-11
First Post: 2018-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients
Sponsor: Medical University of Vienna
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View